There has been a global concern about the issue of gene patenting and several law suites have been under discussions for quite some time now. The United States Supreme Court and the Australian federal courts have dealt with law suites about patenting genes related to breast cancer. A recent article mentions a case of gene patenting raised in Ontario Canada, which focused on the long QT syndrome, a rare disease that is caused by several mutations. As many genes has to be tested altogether in this case, this was bringing more complications to the patenting issues since the owner of the Canadian patent was trying to prevent hospitals from doing some tests. This recent article tells us that advance in technology and new types of diagnostic testing which involve whole genome sequencing and do not require chemically isolated units might help us solve the issues of patenting.